Market Tracker

07/01 5:16pm ET

Galena Biopharma Inc (NASDAQ:GALE)

0.6175
Delayed Data
As of Jul 01
 +0.1514 / +32.48%
Today’s Change
0.28
Today|||52-Week Range
2.49
-57.99%
Year-to-Date
Galena (GALE) Stock Falls on Discontinuation of NeuVax Study
Jun 30 / Zacks.com - Paid Partner Content
The Brexit Vote Is Crushing These 3 Clinical-Stage Biotech Stocks
Jun 24 / MotleyFool.com - Paid Partner Content
Why Galena Biopharma Inc. Is Being Obliterated Today
Jun 29 / MotleyFool.com - Paid Partner Content
Galena Biopharma (GALE) is Overbought: Is A Drop Coming?
Jun 23 / Zacks.com - Paid Partner Content
Galena Craters on Breast Cancer Vaccine Study Failure
Jun 29 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close0.47
Today’s open0.50
Day’s range0.49 - 0.68
Volume53,158,768
Average volume (3 months)4,648,504
Market cap$84.8M
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-23.32%
Earnings growth (this year)+32.68%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book5.58

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...+0.04+9.61%
XENEXenon Pharmaceutical...+0.31+5.25%
SBBPStrongbridge Biophar...-0.25-6.28%
EPIXESSA Pharma Inc0.000.00%
Data as of 4:00pm ET, 07/01/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$59.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark W. Schwartz
Senior VP-Clinical Sciences &
Operations
Gavin S. Choy
Corporate headquarters
San Ramon, California

Forecasts